These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12595628)

  • 1. The -308 polymorphism in the tumour necrosis factor (TNF) gene promoter region and ex vivo lipopolysaccharide-induced TNF expression and cytotoxic activity in Chilean patients with rheumatoid arthritis.
    Cuenca J; Cuchacovich M; Pérez C; Ferreira L; Aguirre A; Schiattino I; Soto L; Cruzat A; Salazar-Onfray F; Aguillón JC
    Rheumatology (Oxford); 2003 Feb; 42(2):308-13. PubMed ID: 12595628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The -308 G/A polymorphism in the tumor necrosis factor-α gene is not associated with development and progression of rheumatoid arthritis in Argentinean patients.
    Aranda F; Perés Wingeyer SD; Schneeberger E; Valerio M; Saint Martin E; Dal Pra F; Correa Mde L; Citera G; Martínez L; Mannucci P; Remondino G; de Larrañaga GF
    Int J Rheum Dis; 2016 May; 19(5):476-81. PubMed ID: 24673827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-alpha -308 promoter polymorphism in patients with rheumatoid arthritis.
    Pawlik A; Florczak M; Ostanek L; Brzosko M; Brzosko I; Szklarz BG
    Scand J Rheumatol; 2005; 34(1):22-6. PubMed ID: 15903021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour necrosis factor a -308 promoter polymorphism in patients with rheumatoid arthritis.
    Rezaieyazdi Z; Afshari JT; Sandooghi M; Mohajer F
    Rheumatol Int; 2007 Dec; 28(2):189-91. PubMed ID: 17763852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
    Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
    Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism in the tumor necrosis factor-alpha gene promoter is associated with severity of rheumatoid arthritis in the Czech population.
    Nemec P; Pavkova-Goldbergova M; Stouracova M; Vasku A; Soucek M; Gatterova J
    Clin Rheumatol; 2008 Jan; 27(1):59-65. PubMed ID: 17562093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-α -308 polymorphism in North Indian rheumatoid arthritis patients and association with mRNA and serum TNF-α.
    Jahid M; Rehan-Ul-Haq ; Jha PK; Chawla D; Avasthi R; Ahmed RS
    Clin Rheumatol; 2017 Oct; 36(10):2209-2216. PubMed ID: 28748515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-alpha gene promoter methylation in Japanese adults with chronic periodontitis and rheumatoid arthritis.
    Kojima A; Kobayashi T; Ito S; Murasawa A; Nakazono K; Yoshie H
    J Periodontal Res; 2016 Jun; 51(3):350-8. PubMed ID: 26247485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could single-nucleotide polymorphisms (SNPs) affecting the tumour necrosis factor promoter be considered as part of rheumatoid arthritis evolution?
    Aguillón JC; Cruzat A; Aravena O; Salazar L; Llanos C; Cuchacovich M
    Immunobiology; 2006; 211(1-2):75-84. PubMed ID: 16446172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour necrosis factor-alpha (TNF-alpha) levels and influence of -308 TNF-alpha promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritis.
    Cuchacovich M; Ferreira L; Aliste M; Soto L; Cuenca J; Cruzat A; Gatica H; Schiattino I; Pérez C; Aguirre A; Salazar-Onfray F; Aguillón JC
    Scand J Rheumatol; 2004; 33(4):228-32. PubMed ID: 15370717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of tumour necrosis factor-alpha -308 G/A promoter polymorphism with susceptibility and disease profile of rheumatoid arthritis.
    Mosaad YM; Abdelsalam A; El-Bassiony SR
    Int J Immunogenet; 2011 Oct; 38(5):427-33. PubMed ID: 21806780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of a human tumor necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritis.
    Kaijzel EL; van Krugten MV; Brinkman BM; Huizinga TW; van der Straaten T; Hazes JM; Ziegler-Heitbrock HW; Nedospasov SA; Breedveld FC; Verweij CL
    Mol Med; 1998 Nov; 4(11):724-33. PubMed ID: 9932110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha promoter -308 A/G polymorphism and rheumatoid arthritis susceptibility: a metaanalysis.
    Lee YH; Ji JD; Song GG
    J Rheumatol; 2007 Jan; 34(1):43-9. PubMed ID: 17143972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of tumor necrosis factor alpha gene polymorphism -857c/t (rs1799724) association in Pakistani rheumatoid arthritis patients.
    Sadaf T; John P; Bhatti A; Jahangir S; Kiani AK; Gill FA; Malik JM
    Int J Rheum Dis; 2016 Nov; 19(11):1119-1125. PubMed ID: 27126784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha -308 promoter polymorphism contributes independently to HLA alleles in the severity of rheumatoid arthritis in Mexicans.
    Rodríguez-Carreón AA; Zúñiga J; Hernández-Pacheco G; Rodríguez-Pérez JM; Pérez-Hernández N; Montes de Oca JV; Cardiel MH; Granados J; Vargas-Alarcón G
    J Autoimmun; 2005 Feb; 24(1):63-8. PubMed ID: 15725578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis.
    Mitchell SA; Grove J; Spurkland A; Boberg KM; Fleming KA; Day CP; Schrumpf E; Chapman RW;
    Gut; 2001 Aug; 49(2):288-94. PubMed ID: 11454808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor promoter polymorphisms in patients with rheumatoid arthritis in Taiwan.
    Yen JH; Chen CJ; Tsai WC; Lin CH; Ou TT; Wu CC; Liu HW
    J Rheumatol; 2001 Aug; 28(8):1788-92. PubMed ID: 11508580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha-308 and -238 polymorphisms in rheumatoid arthritis. Association with messenger RNA expression and sTNF-alpha.
    Oregón-Romero E; Vázquez-Del Mercado M; Ruiz-Quezada SL; Navarro-Hernández RE; Rangel-Villalobos H; Martínez-Bonilla G; Bernard-Medina AG; Armendáriz-Borunda J; García-Bañuelos J; Muñoz-Valle JF
    J Investig Med; 2008 Oct; 56(7):937-43. PubMed ID: 18797411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour necrosis factor 5' promoter single nucleotide polymorphisms influence susceptibility to rheumatoid arthritis (RA) in immunogenetically defined multiplex RA families.
    Waldron-Lynch F; Adams C; Amos C; Zhu DK; McDermott MF; Shanahan F; Molloy MG; O'Gara F
    Genes Immun; 2001 Apr; 2(2):82-7. PubMed ID: 11393661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor (TNF) and TNFR1 polymorphisms are not risk factors for rheumatoid arthritis in a Mexican population.
    Cadena-Sandoval D; Alemán-Ávila I; Barbosa-Cobos RE; Becerril-Mendoza LT; Fragoso JM; Ramírez-Bello J
    Mol Biol Rep; 2018 Jun; 45(3):227-232. PubMed ID: 29404828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.